| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 03/11/2004 | WO2004019974A2 Immunogenic composition comprising an il-13 element and t cell epitopes, and its therapeutic use |
| 03/11/2004 | WO2004019966A1 Method of stabilizing protein solution preparation |
| 03/11/2004 | WO2004019921A2 Use of apoptosis inducing agents in the preparation of a medicament for the treatment of liver diseases |
| 03/11/2004 | WO2004019912A2 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 03/11/2004 | WO2004019911A2 Buccal, polar or non-polar spray or capsule containing drugs for treating endocrine disorders |
| 03/11/2004 | WO2004019910A2 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 03/11/2004 | WO2004019909A2 Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs |
| 03/11/2004 | WO2004019905A1 Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
| 03/11/2004 | WO2004019904A1 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
| 03/11/2004 | WO2004019903A1 Buccal, polar and non-polar spray or capsule containing drugs fortreating metabolic disorders |
| 03/11/2004 | WO2004019891A2 Methods and compostions for immune tolerance |
| 03/11/2004 | WO2004019886A2 Methods for up-regulating antigen expression in tumors |
| 03/11/2004 | WO2004019883A2 Tick polypeptides as anticoagulants and vaccines |
| 03/11/2004 | WO2004019866A2 Compositions and methods for treating cardiovascular disease |
| 03/11/2004 | WO2004019861A2 Stable ph optimized formulation of a modified antibody |
| 03/11/2004 | WO2004019860A2 Formulations of modified antibodies and methods of making the same |
| 03/11/2004 | WO2004019764A2 'diagnosis and treatment of infertility' |
| 03/11/2004 | WO2004019761A2 Methods of treating age-related defects and diseases |
| 03/11/2004 | WO2004007525A3 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 03/11/2004 | WO2003097698A8 Treatment of cancer by the use of anti fas antibody |
| 03/11/2004 | WO2003096782A3 Process for preparing maytansinol |
| 03/11/2004 | WO2003095480A3 Brachyspira hyodysenteriae vaccine |
| 03/11/2004 | WO2003094840A3 Induction of antigen specific immunologic tolerance |
| 03/11/2004 | WO2003086308A3 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 03/11/2004 | WO2003069346A3 Diagnostic method for stroke |
| 03/11/2004 | WO2003068933A3 Optimization of gene sequences of virus-like particles for expression in insect cells |
| 03/11/2004 | WO2003068261A3 Means and methods for altering the motility of the gastrointestinal tract |
| 03/11/2004 | WO2003059395A3 Antisense compounds directed against human csf-1 |
| 03/11/2004 | WO2003059386A3 Prion protein carrier-conjugates |
| 03/11/2004 | WO2003057867A3 Regulation of human fatty acid coa ligase-like amp-binding enzyme |
| 03/11/2004 | WO2003057838A3 Antibodies against the muc18 antigen |
| 03/11/2004 | WO2003057824A3 Compositions and methods for the inhibition of membrane fusion by paramyxoviruses |
| 03/11/2004 | WO2003056010A3 An antisense strategy to modulate estrogen receptor response (er. alpha. and/or er. beta.) |
| 03/11/2004 | WO2003054141A3 Sperm-specific cation channel, catsper2, and uses therefor |
| 03/11/2004 | WO2003049767A3 Method of large scale production of hepatitis a virus |
| 03/11/2004 | WO2003046007A3 Treatment of micro-organism infection |
| 03/11/2004 | WO2003042247A3 Modified anti-tnf alpha antibody |
| 03/11/2004 | WO2003041736A3 Method for the treatment of cardiotoxicity induced by antitumor compounds |
| 03/11/2004 | WO2003039591A3 Allogenic vaccine that contains a costimulatory polypeptide-expressing tumor cell |
| 03/11/2004 | WO2003029288A3 Polypeptides derived from inducible hsp70 and pharmaceutical compositions containing the same |
| 03/11/2004 | WO2003028760A3 Vaccine |
| 03/11/2004 | WO2003026479A3 Methods of suppressing microglial activation |
| 03/11/2004 | WO2003014316A3 Immunomodulatory compositions, formulations, and methods for use thereof |
| 03/11/2004 | WO2003013431A3 Compositions and methods for the therapy and diagnosis of breast cancer |
| 03/11/2004 | WO2002099050A3 Tprs as modifiers of the p53 pathway and methods of use |
| 03/11/2004 | WO2002096349A3 Vaccination against the feline immunodeficiency virus |
| 03/11/2004 | WO2002079441A3 Secreted proteins |
| 03/11/2004 | WO2002072802A3 Live attenuated strains of prrs virus |
| 03/11/2004 | WO2002068602A3 Methods for modulating g2a receptor activity |
| 03/11/2004 | US20040049150 Vaccines |
| 03/11/2004 | US20040049016 The glycoproteins induce apoptosis and can be used as a therapeutic agent against Flavivirus infection and cancer |
| 03/11/2004 | US20040049014 Production of non-immunogenic antibodies having strong affinity for a predetermined antigen |
| 03/11/2004 | US20040048906 Synergistic combinations of amlodipine and atorvastatin used to treat angina pectoris, atherosclerosis, combined hypertension and hyperlipidemia and to treat subjects with symptoms of cardiac risk |
| 03/11/2004 | US20040048819 Complexes for transferring nucleic acids into cells |
| 03/11/2004 | US20040048816 Restenosis treatment |
| 03/11/2004 | US20040048798 Especially CTL polypeptides of specific sequences |
| 03/11/2004 | US20040048790 Inducing cellular immune responses to p53 using peptide and nucleic acid compositions |
| 03/11/2004 | US20040048353 Helicobacter pylori proteins useful for vaccines and diagnostics |
| 03/11/2004 | US20040048338 IL-17 receptor like molecules and uses thereof |
| 03/11/2004 | US20040048336 Comprises adsorption of protective antigen (hemagluttinins) on aluminum hydroxide gel; for prevention of diphtheria, tetanus, pertussis, and hepatitis B in an infant |
| 03/11/2004 | US20040048320 Annexin proteins and autoantibodies as serum markers for cancer |
| 03/11/2004 | US20040048319 Activated leukocyte cell adhesion molecule (ALCAM); immunoglobulins; membrane proteins; for controlling neovascularization; anticancer agents; immunotherapy |
| 03/11/2004 | US20040048294 Diagnostic and therapeutic methods useful for diagnosing and treating diseases, disorders, and/or conditions related to these novel human secreted proteins |
| 03/11/2004 | US20040048266 Regulation of human membrane-type serine protease |
| 03/11/2004 | US20040048245 Isolated polypeptide of given sequence; identifying modulators by contacting with compound and detecting binding activity; use in diagnosis and treatment |
| 03/11/2004 | US20040048235 Methods and compositions for the selective modification of nucleic acids |
| 03/11/2004 | US20040047916 Compositions and methods for the treatme of primary and metastatic neoplastic disea using arsenic compounds |
| 03/11/2004 | US20040047900 Treatment of posterior capsule opacification |
| 03/11/2004 | US20040047882 Use of an oil-in-water emulsion as adjuvant for vaccines to be applied contralaterally, the emulsion comprising approx. 5% squalene, 0.5% polysorbate 80 and 0.5% sorbitan trioleate in aqueous citrate buffer pH 6.5 |
| 03/11/2004 | US20040047881 Delivery of disease control in aquaculture and agriculture using microbes containing bioactive proteins |
| 03/11/2004 | US20040047880 Component for vaccine |
| 03/11/2004 | US20040047879 Vaccine for treating hepatitis B and primary hepatocellular carcinoma |
| 03/11/2004 | US20040047878 DNA vaccine against feline immunodeficiency virus |
| 03/11/2004 | US20040047877 Immunodominant human T-cell epitopes of hepatitis C virus |
| 03/11/2004 | US20040047876 Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins |
| 03/11/2004 | US20040047875 For use in diagnosis, prophylaxis and therapy |
| 03/11/2004 | US20040047874 Inhibition of antigen presentation with poorly catabolized polymers |
| 03/11/2004 | US20040047872 Indicators for monitoring the technique of transcutaneous immunization |
| 03/11/2004 | US20040047871 For conferring protective immunity against F. necrophorum |
| 03/11/2004 | US20040047870 For therapy of atherosclerosis, cardiovascular disease, cerebrovascular disease, peripheral vascular disease, stenosis, restenosis and/or in-stent-stenosis |
| 03/11/2004 | US20040047869 Adjuvant composition comprising an immunostimulatory oligonucleotide and a tocol |
| 03/11/2004 | US20040047867 Adjuvant composition comprising FHA protein or a fragment of FHA protein in its free form |
| 03/11/2004 | US20040047866 Administering to the subject having the Th1- associated autoimmune disease a multivalent conjugate comprising multiple lacto-N-neotetraose (LNnT)-containing oligosaccharides crosslinked to a carrier molecule |
| 03/11/2004 | US20040047860 Antibodies to human mcp-1 |
| 03/11/2004 | US20040047856 Colorstrum-based composition |
| 03/11/2004 | US20040047853 Purified proenzyme of dipeptidyl peptidase i (pro-dppi) |
| 03/11/2004 | US20040047851 Treating a subject suffering from a condition associated with an extracellular zinc sphingomyelinase activity which comprises administering to the subject an amount of a zinc sphingomyelinase inhibitors effective to decrease |
| 03/11/2004 | US20040047848 Induction of immunological tolerance |
| 03/11/2004 | US20040047845 Methods and compositions for diagnosis and treatment of cancer based on the transcription factor ets2 |
| 03/11/2004 | US20040047837 An autologous vaccine to tumor cells is produced by transducing the tumor cells with a herpes virus amplicon containing the gene for an immunomodulatory protein to provide transient expression of the immunomodulatory protein |
| 03/11/2004 | DE10240894A1 Verstärkung der Resorption von Subtanzen über die Haut und Schleimhaut Enhance the absorption of Subtanzen through the skin and mucous membrane |
| 03/11/2004 | CA2497279A1 Mutant forms of meningococcal adp-ribosylating toxin |
| 03/11/2004 | CA2497165A1 Improved bacterial outer membrane vesicles |
| 03/11/2004 | CA2497151A1 Methods for up-regulating antigen expression in tumors |
| 03/11/2004 | CA2497148A1 Tick polypeptides as anticoagulants and vaccines |
| 03/11/2004 | CA2497136A1 Buccal, polar or non-polar spray or capsule containing drugs for treating an infectious disease or cancer |
| 03/11/2004 | CA2497121A1 Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders |
| 03/11/2004 | CA2497116A1 Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma |
| 03/11/2004 | CA2497114A1 Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders |
| 03/11/2004 | CA2497112A1 Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |